Implantable Cardiac Pacemaker Market Rapid Growth By Leading Players Medtronic plc, BIOTRONIK, Inc., Boston Scientific Corporation, St. Jude Medical, Vitatron Holding B.V., Shree Pacetronix Ltd., MEDICO S.p.A., Lepu Medical Technology Co Ltd., LivaNova PL

Implantable Cardiac Pacemaker Market is expected to have a highly positive outlook for the next five years 2018–2026 according to a recently released Implantable Cardiac Pacemaker Market research report. The report has been added in his large database by Coherent Market Insights.

Global Implantable cardiac pacemaker market are engaged in growth activities such as strategic collaborations, mergers and acquisitions to retain leading position in market. For instance, in November 2017, LivaNova PLC and MicroPort Scientific Corporation entered into a binding Letter of Intent (LOI) to sale LivaNova’s Cardiac Rhythm Management (CRM) business franchise to MicroPort for US$ 190 million. Company’s CRM product portfolio includes pacemakers, high-voltage defibrillators, and cardiac resynchronization therapy devices. The acquisition helps MicroPort to add these diverse cardiac rhythm management portfolio to their existing product portfolio.

Download PDF Brochure of This Business Research Report: https://www.coherentmarketinsights.com/insight/request-pdf/1663

Key players in implantable cardiac pacemaker market are focused on research and developmental activities for developing novel compact implantable cardiac pacemakers with better safety and at low cost, thereby increasing product acceptance by healthcare professionals and patients. Moreover, various key players are engaged in obtaining product approval from regulatory authority to increase their geographical reach. For instance, in September 2017, LivaNova PLC and MicroPort Scientific Corporation stated that, their Shanghai-based joint venture MicroPort Sorin Cardiac Rhythm Management Co. Ltd. received the product approval for its family of RegaTM pacemakers from the China Food and Drug Administration. Company’s Rega pacemakers are smallest pacemakers present in the Chinese cardiac pacemakers market, which also offers additional features such as pacing mode which preserves intrinsic conduction, a dual sensor based response rate to exercise and sleep apnea monitoring. In November 2017, Medtronic plc received U.S. Food and Drug Administration (FDA) approval for their portfolio of Azure pacemakers with BlueSync technology, which is available in both single and dual chamber cardiac pacemakers. Company’s new Azure XT MRI and Azure S MRI pacemakers offer improved longevity, which is an estimated at 13.7 years (dual chamber).

Market Dynamics

Market players are engaged in developing novel pacemakers with ability to control the abnormal heart rhythm, monitor and record patient’s heart's electrical activity, blood temperature, and breathing rate. Technological advances in the field of implantable cardiac pacemakers along with increasing prevalence of cardiovascular disease is projected to drive the growth of implantable cardiac pacemaker market over the forecast period.

Request For Customization Of This Business Research Report: https://www.coherentmarketinsights.com/insight/request-customization/1663

Competitive Analysis
Some of the key players operating in implantable cardiac pacemaker market include Medtronic plc, BIOTRONIK, Inc., Boston Scientific Corporation, St. Jude Medical, Vitatron Holding B.V., Shree Pacetronix Ltd., MEDICO S.p.A., Lepu Medical Technology Co Ltd., LivaNova PLC, and Qinming Medical.

Detailed Segmentation:

Global Implantable Cardiac Pacemaker Market, By Product Type:
Single Chamber Pacemaker
Dual Chamber Pacemaker
Biventricular Pacemaker

Global Implantable Cardiac Pacemaker Market, By Application:
Heart Block
Arrhythmia
Atrial fibrillation
Long QT Syndrome
Bradycardia
Tachycardia
Others

Global Implantable Cardiac Pacemaker Market, By End User:
Hospitals
Emergency Care Centers
Others

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

1001 4th Ave,, #3200, Seattle, WA 98154

This release was published on openPR.